A personalized CRISPR treatment for a critically ill baby shows how editing, RNA manufacturing, and delivery are converging into faster, more reproducible therapeutic workflows.
A personalized CRISPR treatment for a critically ill baby shows how editing, RNA manufacturing, and delivery are converging into faster, more reproducible therapeutic workflows.